The time has come to address a significant issue in our nation's drug policy: the classification of cannabis as a Schedule 1 substance.

Under the Controlled Substances Act, a Schedule 1 classification signifies that a drug has a high potential for abuse, has no currently accepted medical use, and lacks accepted safety standards for use under medical supervision.

This categorization places cannabis alongside drugs like heroin and LSD, which grossly misrepresents the nature and potential of cannabis.

Cannabis has been shown in numerous studies to possess significant medical benefits for a variety of conditions, including chronic pain, epilepsy, PTSD, and multiple sclerosis. According to data from the National Center for Complementary and Integrative Health, there is increasing evidence to support the use of cannabis in pain management, especially when traditional therapies have failed.

Furthermore, a Gallup poll conducted in 2021 found that 68% of Americans support the legalization of cannabis, reflecting a significant shift in public perception and understanding of the substance. The current Schedule 1 classification is not only outdated but is also an obstacle to scientific research, leading to unnecessary legal consequences for individuals and stifling potential economic growth that could greatly benefit communities across the U.S.

We urge Donald Trump, who has voiced support for state rights concerning cannabis laws in the past, to take a decisive step towards modernizing our nation's approach to cannabis. By descheduling cannabis from its current Schedule 1 status, we can pave the way for more comprehensive research, better healthcare options, reduced incarceration rates, and enhanced economic opportunities.

Join us in calling for this essential change in policy. Sign the petition today to make your voice heard and to advocate for a future where cannabis is regulated with the nuance and justice it deserves.